Additional Use of Hyaluronic Acid-Based Dissolving Microneedle Patches to Treat Psoriatic Plaques: A Randomized Controlled Trial
Annals of Dermatology · 2025 · 37 (2) · 105
DOI: 10.5021/ad.24.024 ↗At a glance
Randomisierte kontrollierte Studie in Annals of Dermatology, 2025. Written by Hyun Jeong Ju and 6 co-authors. Institution: Department of Dermatology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. Cited 11 times so far (Crossref); 16 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Research Foundation of Korea.
Abstract (original language)
BACKGROUND: Despite advances in systemic targeted therapies, topical agents remain the primary treatment for localized psoriasis. However, their therapeutic effects are often delayed and unsatisfactory. The dissolving microneedle (DMN) patch, a novel transdermal drug delivery system, enhances the absorption of topical agents through micro-channels. OBJECTIVE: To evaluate the efficacy of DMN patches in enhancing drug delivery and improving clinical outcomes in psoriatic plaques. METHODS: A prospective, randomized, split-body study was conducted to verify the efficacy of additional use of DMN patches after topical agent application in psoriasis treatment. Patients with mild psoriasis were enrolled and 6 paired lesions per patient were randomized into 3 groups: ointment-only, ointment-with-no needle patch, and ointment-with-DMN patch. Lesions were treated with a topical agent (betamethasone and calcipotriol) once daily for 2 weeks. Modified psoriasis area and severity index (mPASI) scores were measured weekly. In vitro and ex vivo experiments were performed to confirm micro-channel formation, microneedle dissolution, and drug penetration enhancement. RESULTS: A total of 132 paired lesions from 22 patients were analyzed. The ointment-with-DMN patch group showed significantly improved mPASI scores (80.4%±20.5%; 5.42→1.06) compared to the ointment-with-no needle patch (64.6%±33.0%; 4.94→1.68) (p
Subjects
Author keywords
Authors and institutions
- Department of Dermatology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- RAPHAS Co., Ltd., Seoul, Korea.
- Department of Dermatology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. l.jihaeMD@gmail.com.
ORCID profiles: Hyun Jeong Ju, Ji Yoon Kim, Do Hyeon Jeong, Moon-Su Lee, Gyong Moon Kim, Jung Min Bae, Ji Hae Lee
Funding
- National Research Foundation of Korea
Cite
APA
Ju, H. J., Kim, J. Y., Jeong, D. H., Lee, M. S., Kim, G. M., Bae, J. M., & Lee, J. H. (2025). Additional Use of Hyaluronic Acid-Based Dissolving Microneedle Patches to Treat Psoriatic Plaques: A Randomized Controlled Trial. Annals of Dermatology, 37(2), 105. https://doi.org/10.5021/ad.24.024
Vancouver
Ju HJ, Kim JY, Jeong DH, Lee MS, Kim GM, Bae JM, et al. Additional Use of Hyaluronic Acid-Based Dissolving Microneedle Patches to Treat Psoriatic Plaques: A Randomized Controlled Trial. Annals of Dermatology. 2025;37(2):105. doi:10.5021/ad.24.024
BibTeX
@article{Ju2025,
author = {Ju, Hyun Jeong and Kim, Ji Yoon and Jeong, Do Hyeon and Lee, Moon-Su and Kim, Gyong Moon and Bae, Jung Min and Lee, Ji Hae},
title = {Additional Use of Hyaluronic Acid-Based Dissolving Microneedle Patches to Treat Psoriatic Plaques: A Randomized Controlled Trial},
journal = {Annals of Dermatology},
year = {2025},
volume = {37},
number = {2},
pages = {105},
doi = {10.5021/ad.24.024}
}
EUVIMED